Biobased Anti-Thrombosis Agent

Potent trivalent inhibitors of thrombin from anticoagulation peptides in insect saliva

Thrombosis, the clogging of blood vessels, is a major cause of heart attacks and embolism. Scientists have now engineered the first inhibitors of thrombin, a protease promoting thrombosis, that is three-fold efficient. In a study published in the journal Angewandte Chemie, the authors demonstrate that attacking three sites of the thrombin molecule is more efficient than attacking only two sites, which is the mode of action of many natural agents.

Biobased Anti-Thrombosis Agent - Potent trivalent inhibitors of thrombin from anticoagulation peptides in insect saliva

© Wiley-VCH, re-use with credit to 'Angewandte Chemie' and a link to the original article at https://doi.org/10.1002/anie.202015127

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.